Open AccessYttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study
Author(s) -
Minseok Albert Kim,
Heejoon Jang,
Narak Choi,
Joon Yeul Nam,
Yun Bin Lee,
Eun Ju Cho,
Jeong-Hoon Lee,
Su Jong Yu,
Hyo Cheol Kim,
Jin Wook Chung,
JungHwan Yoon,
Yoon Jun Kim
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s335879
Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , propensity score matching , gastroenterology , confidence interval , transcatheter arterial chemoembolization , cohort , retrospective cohort study , oncology
Both trans-arterial radioembolization (TARE) and conventional trans-arterial chemoembolization (TACE) can effectively control hepatocellular carcinoma (HCC) in patients who are not suitable for curative resection. This study compared the effectiveness of TARE and conventional TACE as the initial trans-arterial treatment for hepatocellular carcinoma (HCC) assessed by tumor response and clinical outcomes.